ArticleJournal of clinical medicine2023

Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.